Gilteritinib-impurities | Pharmaffiliates


Gilteritinib, sold under the brand name Xospata, is an anti-cancer drug. It acts as an inhibitor of FLT3, hence it is a tyrosine kinase inhibitor.Gilteritinib has been repurposed as a potential antiviral drug as a possible application in the treatment of COVID-19. Reference standards of Gilteritinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

PA 07 0840000

Gilteritinib - API

  • Catalogue No.:PA 07 0840000

  • CAS :


  • Molecular Formula : C29H44N8O3

  • Molecular Weight : 552.72